EUROPEAN SOCIETY FOR HYBRID, MOLECULAR AND TRANSLATIONAL IMAGING
CHILI 2018
Lectures
1
CHILI-18 - 18F-FDG PET/CT in oncology with clinical case review
19:48José Vercher-Conejero
2
CHILI-18 - 18F-FDG PET/CT in oncology: Pitfalls with clinical case review
17:45Christina Pfannenberg
3
CHILI-18 - Artificial intelligence in hybrid imaging – the best of all worlds ?
19:10Irène Buvat
4
CHILI-18 - Far beyond FDG: Future targets for new radiopharmaceuticals in hybrid imaging?
20:02Harun Ilhan
5
CHILI-18
03:34Introduction
6
CHILI-18
02:14Introduction
7
CHILI-18
02:01Introduction
8
CHILI-18
01:10Introduction
9
CHILI-18
16:31Panel Discussion
10
CHILI-18 - PET/CT in imaging inflammation, infection and benign tumours
20:38Jean-Noel Talbot
11
CHILI-18 - PET/CT in lymphoma
18:22Francesca Giunta
12
CHILI-18 - PET/CT in melanoma
19:37Helle Westergren Hendel
13
CHILI-18 - PET/CT in neuro-endocrine tumors
16:24Jann Mortensen
14
CHILI-18
16:24Round table discussion
15
CHILI-18
10:53Round table discussion
16
CHILI-18
10:22Round table discussion
17
CHILI-18 - The basics of hybrid imaging
19:35Ivo Rausch
18
CHILI-18 - The role of PSMA hybrid imaging in the clinical management of prostate cancer
22:19Clemens Cyran
19
CHILI-18 - Theragnostics: hybrid imaging and radionuclide therapy
21:07Harun Ilhan
20
CHILI 2018 - Combined PET/MRI: Methods & application
20:31Thomas Beyer
Learning Objectives
- to learn the principles of hybrid medical imaging
- to learn the key clinical questions at different points in the patient’s journey
- to understand the indications, limitations and comparative merits of each part in hybrid medical imaging in a wide range of oncologic and non-oncologic conditions, including lymphoma, melanoma, prostate cancer, as well as neuro-endocrine tumors
- to appreciate the complementary roles of structural and functional/molecular imaging in cancer management
- to understand how information derived from imaging guides patient selection for treatment and supports individualised treatment planning
- to learn about advanced applications of hybrid imaging, such as combined PET/MRI, new radiopharmaceuticals and artificial intelligence in hybrid imaging